Skip to main content
    C

    Cardlytics Inc (CDLX)

    Official site

    COMMUNICATION SERVICES • ADVERTISING AGENCIES • NASDAQ

    $1.29
    +0.00 (+0.00%)

    Market Cap: $7.87M

    Last updated: Nov 17, 2026 at 4:13 PM ET

    Cardlytics Inc (CDLX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Cardlytics (CDLX) has a market cap of $7.87M and an enterprise value of $172.62M. Its share count is up 1003.38% from a year earlier. Its net debt of $164.75M equals 2093.12% of its market cap.

    Total Valuation

    Enterprise value is 2093.12% above the market cap, as debt exceeds cash.

    Market Cap$7.87M
    Enterprise Value$172.62M
    Latest price (Nov 17, 2026)$1.29

    Key Dates

    The next earnings report is expected on Mar 2, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 2, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 2.48% in the quarter ended Sep 30, 2026 and grew 8.62% a year over 2 years.

    Shares Outstanding5.90M
    Shares Change (YoY)+1003.38%
    Shares Change (QoQ)+2.48%
    Share Count Growth (2Y CAGR)+8.62%

    Price Statistics

    The stock is down 90.72% over 52 weeks and trades 48.19% below its 50-day average.

    Beta (1Y)1.11
    52-Week Change-90.72%
    1-Month Change-29.89%
    3-Month Change-69.72%
    6-Month Change-78.36%
    5-Year Change-99.77%
    Total Return (1Y)-90.72%
    Total Return (3Y CAGR)-74.46%
    Total Return (5Y CAGR)-72.07%
    Return vs SPY (1Y)-101.07%
    Max Drawdown (1Y)-91.51%
    Max Drawdown (3Y)-99.36%
    Sharpe Ratio (1Y)-2.49
    Correlation with SPY (1Y)0.17
    50-Day Average$2.49
    200-Day Average$5.63
    52-Week Range$1.26 to $15.55
    RSI (14 Days)27.2
    Average Volume (20 Days)76.05K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.82x current liabilities.

    Current Ratio1.82x
    Quick Ratio1.82x

    Returns and Efficiency

    Return on invested capital is -12.20% over the last 12 months, against a 5-year average of -39.59%.

    Return on Assets (ROA)-16.00%
    Return on Invested Capital (ROIC)-12.20%
    Return on Capital Employed (ROCE)-15.10%
    ROA (5Y Average)-37.08%
    ROIC (5Y Average)-39.59%
    Asset Turnover0.61x
    Receivables Turnover2.41x

    Scores

    CDLX has an Altman Z-Score of -8.21, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score-8.21
    Altman Z ZoneDistress
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $160.18M over the last 12 months is down 31.97% from the 12 months before.

    Revenue$160.18M
    Revenue Growth (YoY)-31.97%
    Gross Profit$160.18M
    Operating Income-$25.23M
    Pretax Income-$38.13M
    Net Income-$36.55M
    EBITDA-$5.02M
    EBIT-$26.50M
    Reported EPS (TTM)-$3.60

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$29.95M
    Total Debt$194.69M
    Net Debt$164.75M
    Net Debt Per Share$27.91
    Working Capital$43.44M
    Shareholder Equity-$23.02M
    Tangible Book Value-$148.63M
    Total Assets$228.51M
    Total Liabilities$251.54M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $9.16M of capital spending, operating cash flow left -$16.29M of free cash flow.

    Operating Cash Flow-$7.13M
    Capital Expenditures$9.16M
    Free Cash Flow-$16.29M
    FCF Per Share-$2.77
    Depreciation and Amortization$21.48M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -15.75%, against a 5-year average of -71.40%.

    Gross Margin100.00%
    Operating Margin-15.75%
    Pretax Margin-23.81%
    Net Margin-22.82%
    EBITDA Margin-3.13%
    EBIT Margin-16.54%
    FCF Margin-10.17%
    Operating Margin (5Y Average)-71.40%
    Net Margin (5Y Average)-71.99%

    Growth

    Revenue fell 7.89% a year over 3 years.

    Revenue Growth (3Y CAGR)-7.89%
    Revenue Growth (5Y CAGR)+4.53%

    Revenue and profit by year

    Dividends and Yields

    CDLX does not pay a dividend. Its free cash flow yield is -214.00%.

    FCF Yield-214.00%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-10 reverse split on Jun 8, 2026.

    Last Split DateJun 8, 2026
    Split TypeReverse split
    Split Ratio1:10

    Peer Position

    Against 7 similar companies, CDLX has the 6th highest ROIC.

    ROIC-12.20% vs 0.70% median
    Revenue Growth (Trailing 4 Quarters, YoY)-31.97% vs -2.08% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -19.48% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-19.48%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About CDLX

    What is CDLX's market cap?

    Cardlytics has a market cap of $7.87M. Its enterprise value, which adds debt and subtracts cash, is $172.62M.

    How many shares of CDLX are outstanding?

    Cardlytics has 5.90M shares outstanding. The count is up 1003.38% from a year earlier.

    Does CDLX pay a dividend?

    No. Cardlytics does not pay a dividend.

    How much debt does CDLX have?

    Cardlytics has $194.69M of total debt and $29.95M of cash and equivalents, a net debt position of $164.75M.